Abstract:Graphene oxide (GO), as a two-dimensional carbon nanosheet, has been extensively studied for potential biomedical applications due to its notable properties. Although a growing number of studies have investigated the adverse effects of GO nanosheets, the available toxicity data concerning GO's effect on the neuronal cells remain highly limited. In this work, we systematically investigated the toxic responses of commercially available GO on a rat pheochromocytoma-derived PC12 cell line, which was an ideal in vitro model to study the neurotoxicity of GO. GO exerted a significant toxic effect on PC12 cells in a dose- and time-dependent manner. GO treatments under doses of 40, 50, and 60 mu g/mL triggered an autophagic response and the blockade of autophagic flux via disrupting lysosome degradation capability. Caspase 9-mediated apoptosis was also observed in GO-treated cells. Moreover, GO-induced apoptosis was relevant to the aberrant accumulation of autophagy substrate p62/SQSTM. Inhibition of the accumulation of autophagic substrate alleviated GO-caused apoptotic cell death. Our findings raise a concern for the putative biomedical applications of GO in the form of diagnostic and therapeutic tools, where its systematic biocompatibility should be thoroughly explored. Statement of significance Graphene oxide (GO) has attracted considerable interests in biomedical fields, which also resulted in numerous safety risks to human bodies. It is urgently required to establish a paradigm for accurately evaluating their adverse effects in biological systems. This study thoroughly explored the neurotoxicity of GO in PC12 cells. We found GO triggered an increased autophagic response and the impairment of autophagic flux, which was functionally involved in cell apoptosis. Inhibition of excessive accumulation of autophagic cargo attenuated apoptotic cell death. Our findings highlight deep considerations on the regulation mechanism of autophagy-lysosomes-apotosis-axis, which will contribute to a better understanding of the neurotoxicity of graphene-family nanomaterials, and provide a new insight in the treatment of cancer cells at nanoscale levels. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Graphene Oxide Improves Postoperative Cognitive Dysfunction by Maximally Alleviating Amyloid Beta Burden in Mice.

Graphene quantum dots conjugated neuroprotective peptide improve learning and memory capability

Graphene Oxide Quantum Dot Alters Amyloidogenicity of Hen Egg White Lysozyme via Modulation of Protein Surface Character

Graphene Oxide Induces P62/sqstm-Dependent Apoptosis Through the Impairment of Autophagic Flux and Lysosomal Dysfunction in PC12 Cells.

Graphene Oxide Attenuates Toxicity of Amyloid‐β Aggregates in Yeast by Promoting Disassembly and Boosting Cellular Stress Response (Adv. Funct. Mater. 45/2023)

Graphene Oxide, a Prominent Nanocarrier to Reduce the Toxicity of Alzheimer's Proteins: A Revolution in Treatment

Insights into Mechanism of Aβ42 Fibril Growth on Surface of Graphene Oxides: Oxidative Degree Matters.

Graphene Oxide Disrupted Mitochondrial Homeostasis Through Inducing Intracellular Redox Deviation and Autophagy-Lysosomal Network Dysfunction in SH-SY5Y Cells

Improved in Vitro and in Vivo Biocompatibility of Graphene Oxide Through Surface Modification: Poly(Acrylic Acid)-Functionalization is Superior to PEGylation.

Distribution and Biocompatibility Studies of Graphene Oxide in Mice after Intravenous Administration

Graphene Oxide Quantum Dots Reduce Oxidative Stress and Inhibit Neurotoxicity in Vitro and in Vivo Through Catalase-Like Activity and Metabolic Regulation

Mechanisms of Oxidative Stress, Apoptosis, and Autophagy Involved in Graphene Oxide Nanomaterial Anti-Osteosarcoma Effect

Destruction of amyloid fibrils by graphene through penetration and extraction of peptides.

Osteocalcin Ameliorates Cognitive Dysfunctions in a Mouse Model of Alzheimer’s Disease by Reducing Amyloid Β Burden and Upregulating Glycolysis in Neuroglia

Biocompatibility of graphene oxide intravenously administrated in mice—effects of dose, size and exposure protocols

Osteocalcin ameliorates cognitive dysfunctions in a mouse model of Alzheimer's Disease by reducing amyloid β burden and upregulating glycolysis in neuroglia

Lipid- and Gut Microbiota-Modulating Effects of Graphene Oxide Nanoparticles in High-Fat Diet-Induced Hyperlipidemic Mice

Effect of Graphene Oxide on Undifferentiated and Retinoic Acid-Differentiated SH-SY5Y Cells Line

The Interrupted Effect of Autophagic Flux and Lysosomal Function Induced by Graphene Oxide in P62-Dependent Apoptosis of F98 Cells

Protein Corona-Mediated Mitigation of Cytotoxicity of Graphene Oxide.

Carboxylated Graphene Oxide Promoted Axonal Guidance Growth by Activating Netrin-1/deleted in Colorectal Cancer Signaling in Rat Primary Cultured Cortical Neurons